AI

The challenges facing the UK’s health-data assets are social, ethical and political rather than technical.

Berlin Bio × AI Hackathon finalist: an agentic system that retrieves, synthesises and grades scientific evidence on ageing interventions.

Reached the final of the Berlin Bio × AI Hackathon and presented AGE-nt, an agentic system that retrieves, synthesises and reasons over complex scientific evidence on ageing interventions.

Chaired the ‘How I Built This: Drug Discovery’ panel at the Scientists to Builders summit at the Francis Crick Institute, with Tim Weaving (CEO, Q Matter) and Chris Thompson (CTO, Micrographia Bio). The summit brought together researchers and early-stage founders on translating AI-driven scientific discovery into real-world impact. Hosted by Conception X, Encode: AI for Science (Pillar VC) and Renaissance Philanthropy, supported by Ada Ventures and the Crick Science Entrepreneur Network, and powered by ARIA.

A randomised, multimethod study with 42 UK clinicians evaluating how an AI clinical decision support system for intravenous-to-oral antibiotic switching influences prescribing decisions, and how clinicians perceive it. The final paper from my PhD.

Helping AI developers find and access medical data 10x faster: an agentic search system that identifies patient cohorts across hospital systems from a natural-language query. Secured a partnership with an imaging informatics company.

As part of the Imperial AI Policy Fellowship programme, I presented my work and took part in a panel on AI in healthcare before governmental policy and decision makers.

Invited to give a talk to an international audiance on my work on Steward.ai, as part of a delegation showcasing the potential of AI for healthcare.

Gave a talk at ESCMID 2025 a leading global conference on infectious diseases on developing and prospectively evaluating an AI clinical decision support system.

Pitched Steward.ai as an innovative AI-powered decision support solution to disrupt antimicrobial resistance and help clinicians achieve precision antibiotic therapy.